Associate Professor Sarah Londrigan is a teaching and research academic in the Department of Microbiology and Immunology at the University of Melbourne, leading a program examining cellular responses to respiratory virus infection. She is a lead for the Viral Infectious Diseases at the Doherty Institute. She completed her undergraduate and PhD studies at the University of Melbourne, where she identified novel cell surface receptors for rotavirus. Sarah’s postdoctoral research at the Walter and Eliza Hall Institute (WEHI) involved creating immunomodulatory adenoviruses that generated local immunosuppression during islet transplantation to treat Type I diabetes. Since 2008, her research has focused on pathways that influenza, and other respiratory viruses, use to infect host cells. Current projects include investigating why particular respiratory viruses are highly pathogenic, leading to very severe disease.
